Found 4 matching trials
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma PHASE3 The purpose of this study is to demonstrate that the study drug exposure le...
Show More Status
Active Not Recruiting
Location
Local Institution - 0125
Learn More & Join Trial
A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab PHASE1 This study will characterize the movement of drugs within the body, evaluat...
Show More Location
Local Institution - 0001
Learn More & Join Trial
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors PHASE1 The purpose of this study is to test the safety and efficacy of BMS-986482 ...
Show More Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Learn More & Join Trial
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations PHASE2 The purpose of this study is to assess the patient's preference for nivolum...
Show More Status
Active Not Recruiting
Location
Local Institution - 0007
Learn More & Join Trial